Evidence map›Paper›PMID 27781299›Full record

ArticleJournal of neuroscience research2017

Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.

Cindy T van Velthoven, Mark Dzietko, Michael F Wendland, Nikita Derugin, Joel Faustino, Cobi J Heijnen, Donna M Ferriero, Zinaida S Vexler

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Childhood stroke.Nature reviews. Disease primers · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cindy T van VelthovenDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Mark DzietkoDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Michael F WendlandDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Nikita DeruginDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Joel FaustinoDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Cobi J HeijnenLaboratory of Neuroimmunology, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Donna M FerrieroDepartment of Neurology, University of California, San Francisco, San Francisco, California.
Zinaida S VexlerDepartment of Neurology, University of California, San Francisco, San Francisco, California.
University of California, San Francisco · USThe University of Texas MD Anderson Cancer Center · US

Funding

White matter injury as predictor of outcome in neonatal brain injuryP50NS035902 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIERO, DONNA M. · 1997 to 2012
$14.0M
Neonatal Stroke: The Role of Microglia-derived Extracellular VesiclesR01NS044025 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VEXLER, ZINAIDA S · 2002 to 2023
$7.7M
Macrophages as modulators of repair after neonatal strokeR01NS076726 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VEXLER, ZINAIDA S · 2012 to 2016
$1.8M
CINC-1 as a modulator of blood-brain barrier integrity after neonatal strokeR01NS055915 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VEXLER, ZINAIDA S · 2009 to 2010
$775k
NINDS NIH HHS P50 NS035902NINDS NIH HHS R01 NS044025NINDS NIH HHS R01 NS055915NINDS NIH HHS R01 NS076726
6 · The paper itself

Abstract

Cell therapy has emerged as a potential treatment for many neurodegenerative diseases including stroke and neonatal ischemic brain injury. Delayed intranasal administration of mesenchymal stem cells (MSCs) after experimental hypoxia-ischemia and after a transient middle cerebral artery occlusion (tMCAO) in neonatal rats has shown improvement in long-term functional outcomes, but the effects of MSCs on white matter injury (WMI) are insufficiently understood. In this study we used longitudinal T2-weighted (T2W) and diffusion tensor magnetic resonance imaging (MRI) to characterize chronic injury after tMCAO induced in postnatal day 10 (P10) rats and examined the effects of delayed MSC administration on WMI, axonal coverage, and long-term somatosensory function. We show unilateral injury- and region-dependent changes in diffusion fraction anisotropy 1 and 2 weeks after tMCAO that correspond to accumulation of degraded myelin basic protein, astrocytosis, and decreased axonal coverage. With the use of stringent T2W-based injury criteria at 72 hr after tMCAO to randomize neonatal rats to receive intranasal MSCs or vehicle, we show that a single MSC administration attenuates WMI and enhances somatosensory function 28 days after stroke. A positive correlation was found between MSC-enhanced white matter integrity and functional performance in injured neonatal rats. Collectively, these data indicate that the damage induced by tMCAO progresses over time and is halted by administration of MSCs. © 2016 Wiley Periodicals, Inc.

Indexed as

Infarction, Middle Cerebral ArteryMagnetic Resonance ImagingAge FactorsAnalysis of VarianceAnimalsAnimals, NewbornBromodeoxyuridineCell- and Tissue-Based TherapyDisease Models, AnimalGene Expression Regulation, DevelopmentalGlial Fibrillary Acidic ProteinImage Processing, Computer-AssistedLectinsMesenchymal Stem CellsMyelin Basic ProteinPsychomotor DisordersBromodeoxyuridineGlial Fibrillary Acidic ProteinLectinsMyelin Basic Proteinaxonbrain repairdiffusion tensor imagingfractional anisotropymiddle cerebral artery occlusionperinatal stroke

Identifiers

PMID27781299
PMCPMC5352529
OpenAlexW2543245084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.